PILL vs. XTJL

Last updated Jun 26, 2026

PILL (Direxion Daily Pharmaceutical & Medical Bull 3X Shares) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. PILL is passively managed, while XTJL is actively managed. Over the past 3 years, PILL returned 28.79%/yr vs 14.42%/yr for XTJL. A 0.58 correlation means they provide meaningful diversification when combined. PILL charges 0.98%/yr vs 0.79%/yr for XTJL.

Performance

PILL vs. XTJL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PILL achieves a 33.93% return, which is significantly higher than XTJL's 5.63% return.

PILL

• 1D: -0.48%
• 1M: 33.79%
• YTD: 33.93%
• 6M: 24.05%
• 1Y: 209.10%
• 3Y*: 28.79%
• 5Y*: -7.05%
• 10Y*: —

XTJL

• 1D: 0.02%
• 1M: 0.38%
• YTD: 5.63%
• 6M: 5.29%
• 1Y: 14.32%
• 3Y*: 14.42%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PILL vs. XTJL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares	33.93%	75.14%	-7.26%	-12.06%	-43.16%	-32.88%
XTJL Innovator U.S. Equity Accelerated Plus ETF - July	5.63%	15.42%	14.43%	25.72%	-15.66%	7.81%

Correlation

The correlation between PILL and XTJL is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.42
Correlation (3Y) Calculated over the trailing 3-year period	0.51
Correlation (All Time) Calculated using the full available price history since Jul 1, 2021	0.58

The correlation between PILL and XTJL shifts across timeframes, from 0.42 (1 year) to 0.58 (all time), reflecting how their relationship changes across market environments.

PILL vs. XTJL - Sectors Allocation Comparison

Sectors	PILL	XTJL
Healthcare	100.0%	8.4%
Basic Materials	-	1.7%
Communication Services	-	10.8%
Consumer Cyclical	-	10.0%
Consumer Defensive	-	4.6%
Energy	-	3.2%
Financial Services	-	11.0%
Industrials	-	7.9%
Real Estate	-	1.8%
Technology	-	38.4%
Utilities	-	2.1%

Return for Risk

PILL vs. XTJL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PILL

PILL Risk / Return Rank: 90
PILL Sharpe Ratio Rank: 95
PILL Sortino Ratio Rank: 87
PILL Omega Ratio Rank: 80
PILL Calmar Ratio Rank: 94
PILL Martin Ratio Rank: 93

XTJL

XTJL Risk / Return Rank: 76
XTJL Sharpe Ratio Rank: 69
XTJL Sortino Ratio Rank: 75
XTJL Omega Ratio Rank: 83
XTJL Calmar Ratio Rank: 65
XTJL Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PILL vs. XTJL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PILL	XTJL	Difference
Sharpe ratio: Return per unit of total volatility	3.37	1.96	+1.41
Sortino ratio: Return per unit of downside risk	3.40	2.92	+0.49
Omega ratio: Gain probability vs. loss probability	1.42	1.44	-0.02
Calmar ratio: Return relative to maximum drawdown	6.34	2.81	+3.53
Martin ratio: Return relative to average drawdown	20.92	15.91	+5.01

PILL vs. XTJL - Sharpe Ratio Comparison

The current PILL Sharpe Ratio is 3.37, which is higher than the XTJL Sharpe Ratio of 1.96. The chart below compares the historical Sharpe Ratios of PILL and XTJL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

PILL vs. XTJL - Drawdown Comparison

The maximum PILL drawdown since its inception was -88.76%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for PILL and XTJL.

Drawdown Indicators

	PILL	XTJL	Difference
Max Drawdown Largest peak-to-trough decline	-88.76%	-23.24%	-65.52%
Max Drawdown (1Y) Largest decline over 1 year	-33.21%	-5.12%	-28.09%
Max Drawdown (3Y) Largest decline over 3 years	-60.43%	-16.70%	-43.73%
Max Drawdown (5Y) Largest decline over 5 years	-83.26%	—	—
Current Drawdown Current decline from peak	-54.11%	-0.04%	-54.07%
Average Drawdown Average peak-to-trough decline	-58.54%	-3.99%	-54.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.04%	0.90%	+9.14%

Volatility

PILL vs. XTJL - Volatility Comparison

Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) has a higher volatility of 18.74% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 0.34%. This indicates that PILL's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PILL	XTJL	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.74%	0.34%	+18.40%
Volatility (6M) Calculated over the trailing 6-month period	48.11%	5.61%	+42.50%
Volatility (1Y) Calculated over the trailing 1-year period	62.66%	7.35%	+55.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.65%	15.12%	+45.53%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.79%	15.12%	+48.67%

PILL vs. XTJL - Expense Ratio Comparison

PILL has a 0.98% expense ratio, which is higher than XTJL's 0.79% expense ratio.

Dividends

PILL vs. XTJL - Dividend Comparison

PILL's dividend yield for the trailing twelve months is around 0.41%, while XTJL has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares	0.41%	0.69%	1.28%	1.83%	0.67%	0.00%	0.00%	0.38%	0.91%	0.10%
XTJL Innovator U.S. Equity Accelerated Plus ETF - July	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both PILL and XTJL in my portfolio?

PILL and XTJL have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PILL or XTJL?

PILL has higher volatility (18.74%) compared to XTJL (0.34%). In terms of maximum drawdown, PILL dropped -88.76% vs XTJL's -23.24%.

Which ETF is better, PILL or XTJL?

On 3-year performance, PILL leads with 28.79% vs 14.42% for XTJL. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 0.34%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, PILL or XTJL?

Over the 3-year period, PILL has performed better with a 28.79% return vs 14.42%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, PILL or XTJL?

XTJL is cheaper with a 0.79% expense ratio, compared with 0.98% for PILL.

Which ETF pays a higher dividend yield, PILL or XTJL?

PILL has the higher dividend yield at 0.41%, compared with 0.00% for XTJL.

What is the main difference between PILL and XTJL?

They also come from different issuers: Direxion and Innovator. Their fees differ too: 0.98% for PILL and 0.79% for XTJL.

Which has better risk-adjusted returns?

PILL currently has the higher Sharpe Ratio (3.37 vs 1.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.